OncoHealth

What OncoHealth does

OncoHealth is a private, digital health company headquartered in Atlanta, Georgia, that delivers oncology-specific software and clinical services to U.S. health plans and employer groups. Founded in 2009, the company has operated in oncology for over twelve years and has been majority-owned by Arsenal Capital Partners since May 2022, with strategic investment from McKesson Corporation. OncoHealth sells two integrated product lines: OneUM™, an oncology-specific utilization management platform that unifies medical and pharmacy benefit drug reviews, radiation therapy procedures, and genetic testing in a single workflow and integrates with health plan portals via single sign-on; and Iris by OncoHealth®, a virtual supportive care service providing 24/7 access to oncology-trained nurses, mental health therapists, and dietitians. The company also offers an Oncology Data, Analytics & Performance module as an add-on for performance insights and reporting.

The company's business model is B2B subscription-based, monetized through enterprise contracts with health plans and employer groups. OncoHealth operates an enterprise field sales motion with a consultative "Request a Demo" go-to-market, targeting payer and employer buyers directly. Its customer base includes 22 health plan partners, 4,000 employer partners, and one named flagship account (Geisinger Health Plan, May 2024), collectively supporting 15M+ members. OncoHealth maintains a 50-state virtual medical group staffed by board-certified oncologists, hematologists, and radiation oncologists to support utilization management decisions and peer-to-peer consultation. The company reports $470M in customer savings in 2025, a 94% provider satisfaction rate, and a consumer NPS above 92, and holds URAC accreditation (through 2027) and NCQA certification (through 2026) that are typically required for payer procurement. Leadership was refreshed in February 2025 with the appointment of Jon Maack as CEO to lead the next phase of growth under Arsenal ownership.

Name

OncoHealth

Legal name

OncoHealth

Website

https://oncohealth.us

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

101–250 employees

Short description

OncoHealth is a private, PE-backed digital health company providing oncology-specific utilization management (OneUM) and virtual supportive care (Iris) to U.S. health plans and employer groups, supported by a 50-state oncology virtual medical group.

Ownership category

akta.pro rank

Product category

Oncology Management Software

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621), Other Ambulatory Health Care Services (6219)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology Telemedicine Platforms (HLALAGAH)

akta.pro secondary industries

Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD), Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)

Keywords

• Oncology utilization management
• Virtual cancer supportive care
• Prior authorization software
• Health plan oncology services
• Oncology data analytics

Headquarters

HQ city

Atlanta

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Oncology Management Services: Subscription-based oncology utilization management and care coordination services delivered to health plans and employers. The model involves recurring fees for platform access, clinical services, and ongoing support, with value demonstrated through measurable savings and improved outcomes.
2. Oncology Supportive Care (Iris): Virtual supportive care services including 24/7 nurse support, mental health care, and nutrition counseling. Delivered as part of integrated oncology management programs to health plans and employer groups, likely as an add-on or bundled service within subscription contracts.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

OncoHealth provides an integrated oncology management platform combining its proprietary OneUM utilization management software with Iris virtual supportive care services for health plans and employer groups. The platform unifies medical and pharmacy benefit drugs, radiation therapy procedures, and genetic testing review, while delivering 24/7 access to oncology-trained nurses, mental health therapists, and dietitians to address the clinical, emotional, and financial complexities of cancer care. The offering is anchored by the nation's first oncology-focused 50-state virtual medical group.

Product overview

OncoHealth offers a market-leading integrated oncology software and services platform that combines oncology management services with supportive care. The platform is anchored by two core products: OneUM™ for utilization management and Iris by OncoHealth® for supportive care, supported by Oncology Data, Analytics & Performance. The platform ensures members with cancer receive appropriate treatment and support through services including 24/7 oncology nursing, mental health, nutrition, and resource navigation.

Differentiator

Problem solved

Functional benefit

Brands

• OneUM: Oncology-specific utilization management solution that streamlines prior authorizations, ensuring clinically appropriate, evidence-based care. Unifies medical and pharmacy benefit drugs, radiation therapy procedures and genetic testing in a single platform.
• Iris by OncoHealth

Products and services

• OneUM

Quantifiable outcome

• $470M delivered in customer savings in 2025
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Ovarian Cancer Research AllianceminorStrategic or Co-development Partner · 1 June 2025Ovarian Cancer Research Alliance partnered with Iris by OncoHealth in June 2025 to expand access to the Steps Counseling Program, a supportive care initiative for ovarian cancer patients and their families.
• Geisinger Health PlancoreStrategic or Co-development Partner · 1 May 2024Geisinger Health Plan partnered with OncoHealth in May 2024 to provide comprehensive cancer support to Geisinger members. The partnership leverages OncoHealth's oncology management solutions and Iris supportive care services.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Flatiron Health: Flatiron Health (a Roche company) builds oncology-specific EHR and real-world evidence platforms; it serves biopharma and providers with oncology data, a more upstream adjacency to OncoHealth's analytics work.
• Thyme Care: Thyme Care is an oncology navigation and care management company serving health plans and providers; it overlaps with OncoHealth's Iris supportive care and member engagement layer.
• Jasper Health: Jasper Health offers a cancer care platform with navigation, mental health, and care coordination, competing with Iris in the employer and payer supportive care segment.
• COTA Healthcare: COTA provides oncology-specific real-world data and analytics used by providers, payers, and life sciences companies, overlapping with OncoHealth's Data, Analytics & Performance offering.

Broad incumbents

• Optum (UnitedHealth Group): Optum owns EviCore and operates one of the largest healthcare services and analytics platforms in the U.S., giving it structural advantages in oncology UM, payer relationships, and data.
• McKesson Corporation: McKesson is both an OncoHealth investor and the largest U.S. oncology drug distributor with its own specialty provider and biopharma services; it competes broadly in oncology services and is a strategically aligned incumbent.

Direct peers

• EviCore (Evernorth): EviCore, owned by Cigna's Evernorth, is the largest U.S. specialty utilization management vendor and a direct competitor in oncology UM, prior authorization, and evidence-based review for health plans.
• AIM Specialty Health: AIM Specialty Health, part of Elevance Health (Anthem), provides oncology utilization management and specialty health solutions to health plans, directly competing with OncoHealth's OneUM in the payer market.
• New Century Health: New Century Health focuses on oncology and cardiology value-based care and UM for Medicare Advantage and commercial payers; it is one of the closest specialty-specific competitors to OncoHealth's OneUM.

Others

• TailorMed: TailorMed provides financial toxicity navigation and assistance for cancer patients, addressing a pain point that OncoHealth's Iris supportive care also targets, making it an adjacent rather than directly competing peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/oncohealth
• Xx.com/oncohealth_us

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OncoHealth